Clinical Trials List
2024-07-01 - 2032-04-07
Phase III
Recruiting5
ICD-10M32.0
Drug-induced systemic lupus erythematosus
ICD-10M32.10
Systemic lupus erythematosus, organ or system involvement unspecified
ICD-10M32.11
Endocarditis in systemic lupus erythematosus
ICD-10M32.12
Pericarditis in systemic lupus erythematosus
ICD-10M32.13
Lung involvement in systemic lupus erythematosus
ICD-10M32.14
Glomerular disease in systemic lupus erythematosus
ICD-10M32.15
Tubulo-interstitial nephropathy in systemic lupus erythematosus
ICD-10M32.19
Other organ or system involvement in systemic lupus erythematosus
ICD-10M32.8
Other forms of systemic lupus erythematosus
ICD-10M32.9
Systemic lupus erythematosus, unspecified
ICD-9710.0
Systemic lupus erythematosus
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 黃建中 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 謝佳偉 風濕免疫科
- 廖育婉 風濕免疫科
- 吳沂達 風濕免疫科
- WEN-NAN HUANG 風濕免疫科
- 譚國棟 風濕免疫科
- 林靖才 風濕免疫科
- 曾智偉 風濕免疫科
- HSIN-HUA CHEN 風濕免疫科
- 陳彥如 風濕免疫科
- LIN-SHIEN Fu Division of Pediatrics
- Yi-Hsing Chen 無
- 顏在弘 風濕免疫科
- 洪維廷 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- KUO-WEI YEH 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡弘正 Division of Rheumatology
- Wei-Sheng Chen Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16-24 participants
-
Global
550 participants
